NUTRILINQ
Live / Applied — Statement of use — non-final action mailed (as of 21 Jan 2026)
What this means for you
Not registered yet, but its 24 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98568657
- Mark type
- Stylized text
- Filed
- 24 May 2024
- Published for opposition
- 31 Dec 2024
- Attorney of record
- Kevin Matthew Welch
Goods and services
- Class 040 — Treatment of materials: Custom manufacturing of dietary supplements for humans
Owner
- Kelker Pharma, Inc., Hermosa Beach, CA, US
- Kelker Pharma, Inc., Hermosa Beach, CA, US
Prosecution history
- 21 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Jan 2026 — NON-FINAL ACTION E-MAILED
- 21 Jan 2026 — SU - NON-FINAL ACTION - WRITTEN
- 19 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Jul 2025 — USE AMENDMENT FILED
- 19 Jan 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
- 25 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 31 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Dec 2024 — PUBLISHED FOR OPPOSITION
- 25 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Dec 2024 — ASSIGNED TO EXAMINER
- 02 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 May 2024 — NEW APPLICATION ENTERED